Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| prostate cancer management |
|
Blackwell Synergy - Eur J Cancer Care, Volume 16 Issue 6 Page 461 Once detected, prostate cancer does require a management strategy. The different management strategies for early stage prostate cancer will be explored Amazon.com: Management of Prostate Cancer: Books: Ralph A., M.D. Amazon.com: Management of Prostate Cancer: Books: Ralph A., MD Straffon,Eric A. Klein by Ralph A., MD Straffon,Eric A. Klein. guidelines on the management of prostate cancer GUIDELINEs ON THE MANAGEMENT OF PROSTATE CANCER A document for local expert groups preparing prostate cancer management policy documents Prima Project For more than six decades androgen ablative therapies are the state of the art in the management of prostate cancer. Unfortunately, this treatment should be Prostate Cancer Treatment (PDQ®) Takayama TK, Vessella RL, Lange PH: Newer applications of serum prostate-specific antigen in the management of prostate cancer. Semin Oncol 21 (5): 542-53, Prostate Cancer Risk Management Programme â” Department of Primary For further information on the NHS Prostate Cancer Risk Management Programme please see the National Electronic Library for Cancer and the NHS Cancer AUAnet | Clinical Guidelines | Prostate Cancer (2007) Prostate Cancer (2007). Full Report · Appendixes · Abbreviations and Acronyms. MJA: Frydenberg et al., Management of localised prostate cancer Most patients with localised prostate cancer will be given three management options: watchful waiting, radiotherapy, or radical surgery. Prostate Cancer Management Urology: Hematology and Oncology: Prostate Cancer Management. Prostate Cancer Risk Management Programme In September 2002 all General Practitioners in the UK received a copy of the Prostate Cancer Risk Management Programme (PCRMP) guidelines advising GPs how Prostate Cancer Staging Hematology and Oncology Index, Bladder Cancer, Bladder Cancer Staging, Prostate Cancer, Prostate Cancer Staging, Prostate Cancer Management, Testes Cancer Diagnosis and Treatment of Prostate Cancer - April 1, 1998 At present, chemotherapy cannot cure disseminated prostate cancer. Watchful waiting is a reasonable management alternative for prostate cancer in an older Prostate Cancer Management The critical focus for the treatment prostate cancer is to treat those cancers where it is necessary, and not to treat those that do not need it. Prostate : BC Cancer Agency BC Cancer Agency >> Health Professionals Info >> Cancer Management Guidelines Patient Information Document: Screening for Prostate Cancer with PSA Aim of Prostate Cancer Risk Management The aim of Prostate Cancer Risk Management is to ensure that men who are concerned about the risk of prostate cancer receive clear and balanced information Prostate Cancer Risk Management There is no organised screening programme for prostate cancer but an informed choice programme, Prostate Cancer Risk Management, has been introduced. Prostate Cancer - Management of Prostate Cancer Management of localized prostate cancer is a controversial issue, in part because the natural history of localized prostate cancer has been only segmentally eMedicine - Prostate Cancer: Management of Localized Disease Prostate Cancer: Management of Localized Disease - Prostate cancer is one of the most common cancers among males and the second leading cause of death from |
| prostate cancer management |
|
location prostate gland massage nurse prostate hemorrhoids surgery side effects prostate normal sized prostate |